CRBU

Caribou Biosciences, Inc.

CIK 0001619856 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)

$1.66

↑ 0.05 (3.11%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Options; Risks: Fundamentals, Technicals

Key stats

Market Cap

$177.97M

P/E Ratio

-1.72

EPS

-1.59

Dividend Yield

Not covered

52W Position

13%

Beta

2.25

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

1.81

P/S

17.73

EV/Revenue

15.12

ROE

-105.4%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%

$1.38$3.54

Latest Financials

2025-12-31 FY

Revenue

$11.16M

Net Income

-$148.13M

Total Assets

$175.37M

Free Cash Flow

-$112.35M

CRBU

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

CRBU

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news